Suppr超能文献

使用碘海醇清除率测定重度慢性肾衰竭患者的肾小球滤过率——不同清除技术之间的比较

The use of iohexol clearance to determine GFR in patients with severe chronic renal failure--a comparison between different clearance techniques.

作者信息

Frennby B, Sterner G, Almén T, Hagstam K E, Hultberg B, Jacobsson L

机构信息

Department of Diagnostic Radiology, Malmö General Hospital, University of Lund, Sweden.

出版信息

Clin Nephrol. 1995 Jan;43(1):35-46.

PMID:7697934
Abstract

UNLABELLED

The nonionic low-osmolar contrast medium iohexol was used as marker of glomerular filtration rate (GFR) in 53 patients with stable renal function (group I: n = 32, group II: n = 21). All the patients had clearance values < or = 30 ml.min-1.1.73 m-2 body surface; 40 patients < 20 ml.min-1.1.73 m-2 body surface. Simultaneous determinations of renal clearance and plasma clearance, both as slope clearance and single sample clearance, were performed after intravenous injection of 10 ml iohexol 300 mg iodine/ml. In groups I and II plasma was sampled early (around 3 hours) and late (up to 24 hours) after the injection. In group I urine was collected during four 40-minute periods and in group II during one 3-hour period and in group II the residual urine was estimated by ultrasound. Plasma and urine iodine concentrations were analyzed with X-ray fluorescence technique (Reanalyzer PRX90, Provalid AB, Sweden). In group II S-creatinine and tubular function test were followed to detect any signs of nephrotoxicity. In 6 anuric patients (group III) 10 ml iohexol 300 mg I/ml was injected to assess its extrarenal clearance. In groups I and II the slope clearance correlated excellently with the single sample clearance (r = 0.99) when a late plasma sample was used in both techniques. In group II, where residual urine was estimated by ultrasound, renal clearance correlated better with slope clearance than in group I (r = 0.94 vs r = 0.89). There were no signs of nephrotoxicity in the parameters noted. In group III, extrarenal plasma clearance of iohexol did not exceed 2 ml.min-1.1.73 m-2.

CONCLUSION

GFR < 20 ml/min can accurately and safely be determined as renal clearance or plasma clearance of iohexol after an intravenous dose of 10 ml 300 mg I/ml. Plasma clearance techniques, which have the practical clinical advantage of no urine sampling, do at low GFR require a late plasma sample taken, for instance, 24 hours after injection of iohexol, irrespective of whether slope technique or single sample technique or one-compartment or poly-compartment models are used.

摘要

未标注

将非离子型低渗造影剂碘海醇用作53例肾功能稳定患者(I组:n = 32,II组:n = 21)肾小球滤过率(GFR)的标志物。所有患者的清除率值≤30 ml·min⁻¹·1.73 m⁻²体表面积;40例患者<20 ml·min⁻¹·1.73 m⁻²体表面积。静脉注射10 ml碘海醇300 mg碘/ml后,同时测定肾清除率和血浆清除率,包括斜率清除率和单次样本清除率。I组和II组在注射后早期(约3小时)和晚期(长达24小时)采集血浆样本。I组在四个40分钟时间段内收集尿液,II组在一个3小时时间段内收集尿液,II组通过超声估算残余尿量。采用X射线荧光技术(瑞典Provalid AB公司的Reanalyzer PRX90)分析血浆和尿液碘浓度。II组监测血肌酐和肾小管功能试验以检测任何肾毒性迹象。对6例无尿患者(III组)注射10 ml碘海醇300 mg I/ml以评估其肾外清除率。在I组和II组中,当两种技术均使用晚期血浆样本时,斜率清除率与单次样本清除率相关性极佳(r = 0.99)。在II组中,通过超声估算残余尿量,肾清除率与斜率清除率的相关性优于I组(r = 0.94对r = 0.89)。在所记录的参数中未发现肾毒性迹象。在III组中,碘海醇的肾外血浆清除率不超过2 ml·min⁻¹·1.73 m⁻²。

结论

静脉注射10 ml 300 mg I/ml碘海醇后,可将GFR<20 ml/min准确且安全地测定为碘海醇的肾清除率或血浆清除率。血浆清除率技术具有无需采集尿液样本的实际临床优势,但在低GFR时,无论采用斜率技术、单次样本技术还是一室或多室模型,都需要在注射碘海醇后例如24小时采集晚期血浆样本。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验